Oramed PharmaceuticalsORMP
13F holders, Q2 2025 (June 30)At the end of Q2 2025, 47 institutions reported holding Oramed Pharmaceuticals Inc. (ORMP) in their 13F filings, down 5 from Q1 2025. 4 opened new positions and 9 sold out. The largest holders were BML Capital Management, LLC ($6.9M), Murchinson Ltd. ($3.9M) and Boothbay Fund Management, LLC ($1.9M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Oramed Pharmaceuticals Inc.
- CUSIP
- 68403P203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $34K |
| Exits | 9 | $740K |
All 13F filers, Q1 2025 → Q2 2025: 199,203 shares bought and 719,768 shares sold, net −520,565 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| BML Capital Management, LLC | 5.32% | Add +2.1% | 3,083,253 | $6.9M |
| Murchinson Ltd. | 2.23% | Reduce -0.0% | 1,751,559 | $3.9M |
| Boothbay Fund Management, LLC | 0.06% | Reduce -0.0% | 845,391 | $1.9M |
| Rathbones Group PLC | 0.00% | Reduce -1.6% | 233,018 | $524K |
| Dimensional Fund Advisors LP | 0.00% | Add +18.3% | 166,899 | $376K |
| Renaissance Technologies | 0.00% | Add +1.2% | 144,200 | $324K |
| Bank of America Corp. | 0.00% | Reduce -12.4% | 143,406 | $323K |
| Citadel Advisors | 0.00% | Add +264493.9% | 87,316 | $196K |
| BlackRock, Inc. | 0.00% | Reduce -7.3% | 85,570 | $193K |
| Peapod Lane Capital LLC | 0.19% | Reduce -66.4% | 84,779 | $191K |
| State Street Corp. | 0.00% | Add +1.9% | 66,451 | $150K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Reduce -30.6% | 60,449 | $136K |
| Susquehanna International Group, LLP | 0.00% | Reduce -51.7% | 48,428 | $109K |
| Royal Bank of Canada | 0.00% | Reduce -45.3% | 47,591 | $107K |
| Squarepoint Ops LLC | 0.00% | Reduce -3.0% | 46,070 | $104K |
| RBF Capital, LLC | 0.00% | No change | 42,947 | $97K |
| Jane Street Group, LLC | 0.00% | Reduce -36.9% | 42,367 | $95K |
| Morgan Stanley | 0.00% | Reduce -10.4% | 32,095 | $72K |
| Geode Capital Management, LLC | 0.00% | Reduce -4.6% | 24,282 | $55K |
| PNC Financial Services Group, Inc. | 0.00% | Reduce -11.4% | 23,200 | $52K |
| Wells Fargo & Company | 0.00% | No change | 20,986 | $47K |
| American Century Companies Inc. | 0.00% | No change | 19,591 | $44K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Add +36.2% | 18,799 | $41K |
| Sage Capital Management, LLC | 0.02% | No change | 16,750 | $38K |
| LPL Financial LLC | 0.00% | Add +5.0% | 14,685 | $33K |
| Barclays PLC | 0.00% | No change | 13,198 | $30K |
| UBS Group AG | 0.00% | Reduce -64.1% | 12,779 | $29K |
| Altshuler Shaham Ltd | 0.00% | No change | 11,854 | $27K |
| TrinityBridge Ltd | 0.00% | No change | 11,675 | $26K |
| Glass Jacobson Investment Advisors llc | 0.01% | No change | 10,540 | $24K |
| Mariner, LLC | 0.00% | New | 10,086 | $23K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 8,826 | $20K |
| Osaic Holdings, Inc. | 0.00% | Reduce -5.1% | 4,317 | $10K |
| Raymond James Financial Inc. | 0.00% | New | 3,576 | $8K |
| Huntington National Bank | 0.00% | No change | 3,002 | $7K |
| MAI Capital Management | 0.00% | No change | 2,055 | $5K |
| National Bank of Canada | 0.00% | No change | 2,000 | $4K |
| SBI Securities Co., Ltd. | 0.00% | No change | 1,635 | $4K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1,575 | $4K |
| NFSG Corp | 0.00% | New | 1,000 | $2K |
| McIlrath & Eck, LLC | 0.00% | No change | 1,000 | $2K |
| IFP Advisors, Inc | 0.00% | No change | 500 | $1K |
| Jones Financial Companies LLLP | 0.00% | No change | 500 | $1K |
| Golden State Wealth Management, LLC | 0.00% | No change | 303 | $682 |
| Allworth Financial LP | 0.00% | New | 300 | $675 |
| Beacon Capital Management, LLC | 0.00% | No change | 219 | $493 |
| Hopwood Financial Services, Inc. | 0.00% | No change | 200 | $450 |
"% of holder's portfolio" is ORMP's weight in each manager's 13F, not the share of Oramed Pharmaceuticals Inc. the manager owns.